NYT Reports KG To Acquire Abuse-Resistant Drug
Tweet
Share
E-mailGet Alerts KG Hot Sheet
Join SI Premium – FREE
The New York Times reported King Pharmaceuticals (NYSE: KG) plans to obtain the rights to an abuse-resistant version of painkiller OxyContin from biotech company Pain Therapeutics. The announcement is expected sometime today.
You May Also Be Interested In
- Humana surges: Barclays bets big on Medicare star ratings rebound
- CoreCivic shares slip following unexpected CEO transition
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
ContributorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
